Modern Alpha Content Hub Why CXSE Stands Out Among Top China ETFs By Nick Peters-GoldenAugust 2, 2023
Modern Alpha Content Hub 3 WisdomTree ETFs At or Near This Key Buy Signal By Nick Peters-GoldenApril 18, 2023
Modern Alpha Content Hub Why China Reopening ETF CXSE Can Perform in 2023 By Nick Peters-GoldenJanuary 24, 2023
Modern Alpha Content Hub Eye China Consumers in Reopening in CXSE By Nick Peters-GoldenDecember 8, 2022
Modern Alpha Content Hub A Guide to the WisdomTree Rebalance Making Waves in EM By Karrie GordonOctober 26, 2022
Modern Alpha Content Hub WisdomTree Launches Ex-China, Ex-SOE Emerging Market ETF By Karrie GordonSeptember 22, 2022
Modern Alpha Content Hub See Opportunity in China? CXSE Invests in Non-State-Owned Companies By Karrie GordonJune 30, 2022
China Insights Content Hub Chinese Tech Quietly Gains as U.S. Equities Panic By Dan MikaJune 21, 2022
Modern Alpha Content Hub Biotech and Delisting Risk From China’s Perspective with WisdomTree By Karrie GordonMay 19, 2022
Modern Alpha Content Hub Putting the China Equity Conversation Into Proper Context By Tom LydonDecember 29, 2021
Modern Alpha Content Hub China Script Flipped This Year, but Sound ETF Ideas Are Still Out There By Tom LydonNovember 18, 2021
Modern Alpha Content Hub How China’s Zero-Tolerance COVID-19 Policy Affects Stocks By Tom LydonNovember 17, 2021
Modern Alpha Content Hub Are Chinese Stocks Almost Buys? It’s a Matter of Perspective By Tom LydonSeptember 22, 2021
Modern Alpha Content Hub As Retail Investors Pour into Chinese Stocks Again, Consider CXSE By Tom LydonAugust 26, 2021
